首页> 外文OA文献 >MI130004, a Novel Antibody–Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors

【2h】

MI130004, a Novel Antibody–Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors

机译：MI130004是一种新型抗体 - 药物缀合物与海洋源分子结合曲妥珠单抗，表现出对同性恋的肿瘤的体内活性突出

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Pablo Avilés; Juan Manuel Domínguez; María José Guillén; María José Muñoz-Alonso; Cristina Mateo; Raquel Rodriguez-Acebes; José Manuel Molina-Guijarro; Andrés Francesch; Juan Fernando Martínez-Leal; Simon Munt; Carlos M. Galmarini; Carmen Cuevas;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. MI130004, a Novel Antibody-Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors [J] . Aviles Pablo, Manuel Dominguez Juan, Jose Guillen Maria, Molecular cancer therapeutics . 2018,第4期

机译：MI130004，一种新的抗体 - 药物缀合物与海洋源分子结合的曲妥珠单抗，表现出对EM2-表达肿瘤的体内活性突出
2. MI130004, an antibody-drug conjugate including a novel payload of marine origin: Evidences of in vivo activity [J] . Aviles P. M., Guillen M. J., Dominguez J. M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：MI130004，一种包含新的海洋来源有效负载的抗体-药物偶联物：体内活性的证据
3. MI130110, a new antibody-drug conjugate combining an anti-CD13 antibody and a payload of marine origin shows remarkable in vivo activity [J] . Aviles P., Guillen M. J., Dominguez J. M., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：MI130110是一种新的抗体-药物结合物，结合了抗CD13抗体和海洋有效负载，具有出色的体内活性
4. KTN0182A, an Anti-KIT, Pyrrolobenzodiazepine (PBD)-Containing Antibody Drug Conjugate (ADC) Demonstrates Potent Antitumor Activity In Vitro and In Vivo Against a Broad Range of Tumor Types [C] . Sergio Trombetta, Christine Lubeski, Gary C. Kemp, PEGS . 2015

机译：KTN0182A，抗试剂盒，吡咯唑二氮杂己酮（PBD）抗体药物缀合物（ADC）在体外和体内抗抗肿瘤类型的抗肿瘤活性
5. A New Hybrid Agent-Based Model to Evaluate Antibody-Drug Conjugates in Solid Tumors [D] . Menezes, Bruna. 2021

机译：基于杂种代理的基于模型，以评估固体瘤中的抗体 - 药物缀合物
6. Chemically-defined antibody- and small molecule-drug conjugates for in vivo tumor targeting applications: a comparative analysis [O] . Samuele Cazzamalli, Alberto Dal Corso, Fontaine Widmayer, -1

机译：用于体内肿瘤靶向应用的化学定义的抗体和小分子药物偶联物：比较分析
7. Anti-cancer Antibody Trastuzumab-Melanotransferrin Conjugate (BT2111) for the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brain: an In-Vivo Study [O] . Mohamed Ismail Nounou, Chris E. Adkins, Evelina Rubinchik, 2016

机译：抗癌抗体曲妥珠单抗 - 甜菜转移蛋白共轭（BT2111）用于治疗大脑中转移性HER2 +乳腺癌肿瘤：体内研究

MI130004, a Novel Antibody–Drug Conjugate Combining Trastuzumab with a Molecule of Marine Origin, Shows Outstanding In Vivo Activity against HER2-Expressing Tumors

著录项

相似文献

相关主题

期刊订阅